key: cord-0958709-xg53p4sv authors: Liu, Xuefeng; Mondal, Abdul M. title: Conditional cell reprogramming for modeling host‐virus interactions and human viral diseases date: 2020-06-16 journal: J Med Virol DOI: 10.1002/jmv.26093 sha: fa1aee4ec8c7314651a2452087baf8b3baf25d1e doc_id: 958709 cord_uid: xg53p4sv Conventional cancer and transformed cell lines are widely used in cancer biology and other fields within biology. These cells usually have abnormalities from the original tumor itself, but may also develop abnormalities due to genetic manipulation, or genetic and epigenetic changes during long‐term passages. Primary cultures may maintain lineage functions as the original tissue types, yet they have a very limited life span or population doubling time because of the nature of cellular senescence. Primary cultures usually have very low yields, and the high variability from any original tissue specimens, largely limiting their applications in research. Animal models are often used for studies of virus infections, disease modeling, development of antiviral drugs, and vaccines. Human viruses often need a series of passages in vivo to adapt to the host environment because of variable receptors on the cell surface and may have intracellular restrictions from the cell types or host species. Here, we describe a long‐term cell culture system, conditionally reprogrammed cells (CRCs), and its applications in modeling human viral diseases and drug discovery. Using feeder layer coculture in presence of Y‐27632 (conditional reprogramming, CR), CRCs can be obtained and rapidly propagated from surgical specimens, core or needle biopsies, and other minimally invasive or noninvasive specimens, for example, nasal cavity brushing. CRCs preserve their lineage functions and provide biologically relevant and physiological conditions, which are suitable for studies of viral entry and replication, innate immune responses of host cells, and discovery of antiviral drugs. In this review, we summarize the applications of CR technology in modeling host‐virus interactions and human viral diseases including severe acute respiratory syndrome coronavirus‐2 and coronavirus disease‐2019, and antiviral discovery. cell senescence, and they also have very low yields and high variability from any original tissue specimens. As PDCM described above, organoids, iPSCs, and CRCs have been used for the generation or expansion of human normal cells, and these serve as great resources for cell biology and modeling human diseases including viral infections and antiviral discovery. 1, 2 We summarize the characteristics of these approaches in Table 1 . In this review, we focus on the applications of CRCs in modeling host-virus interactions and human viral diseases, and antiviral discovery. 2 | CONDITIONAL CELL REPROGRAMMING We initially discovered that combination of feeder layers and a Rho kinase inhibitor, Y-27632, allows the generation of long-term cultures of both normal and tumor cells from keratinocyte and non-keratinocytes tissues. [3] [4] [5] [6] The culture condition may convert or reprogram the whole-cell populations in synthetic medium to a stem cell-like status within 2 days, rather than a long-term clonal selection. 3, 4 These Reprogrammed cells quickly stop proliferating or differentiate after removal of one of the culture conditions, either Y-27632 or feeder layer. Usually typical epithelial cell colonies are surrounded by feeder cells that can be visualized within 18 to 36 hours after initial plating from single-cell suspension. Thus, we termed this cell technology as "conditional reprogramming (CR)," and the resulting cells as "conditionally reprogrammed cells (CRC)," respectively. 1,3-6 As normal CRCs maintain their lineages and differentiation functions under in vitro three-dimensional (3D) or in vivo conditions, the CR technology has been widely used in basic and translational cancer biology, disease modeling, tissue regeneration, evaluation of drug toxicity, virus infections, and so on. Indeed, organoids 7-11 and CR technologies have been both recognized as the key new technologies by NIH precision oncology, 12, 13 and have also been used CR method is generally applicable to many tissue types including nasal, oropharynx, pharynx, laryngeal, trachea, bronchial, lung, breast, skin, kidney, prostate, bladder, salivary gland, oral cavity, esopharyngx, stomach, small intestine, colon, liver, and neuroendocrine or endocrine tissues 3, 4, (Figure 1 ). CR is also applicable to several mammalian species such as horse, dog, mouse, rat, ferret, and cow. 47 Originally, the CR used irradiated mouse fibroblast cells (swiss mouse 3T3, J2 clone) and the Rho-associated kinase inhibitor (Y-27632) to propagate epithelial cells. 3, 5, 6 A few improvements have been used to simplify protocols using J2 conditioned medium, 3,5,6 hypoxia condition (1-2% O 2 ), 60 and combination with mTOR or TGF-beta, and SMAD inhibition [61] [62] [63] in the presence of Y-27632. CR technology is simple and cheap as there is no need for expensive reagents as matrigel for organoids, and robust as 1 × 10 6 cells can be generated from a needle biopsy within 7 days, and rapid as the whole populations of cells can be reprogrammed within 2 days instead of needing clonal selection. Figure 1 shows a diagram of normal cell cultures in CR conditions for long-term cultures and 3D (ALI, air-liquid interface; LLI, liquid-liquid interface; and organoids) conditions for ex vivo models of airway epithelial cells. As shown in Figure Human bocavirus 1 (HBoV1) often infects children and causes acute respiratory tract illness, such as pneumonia, induces, asthma exacerbations, and/or bronchiolitis, and some are life-threatening. 102 It has been shown that HBoV1 may infect well-differentiated or polarized human primary airway epithelium cultured at ALI cultures. 103 in HBoV1 genome amplification in ALI system. This is the first report to show that parvovirus DNA replicates in non-dividing cells autonomously. 104 Then, they also discovered that HBoV1 infection activates antiapoptotic proteins, thereby suppressing apoptosis but promoting pyroptosis. 105 Thus, CR-coupled ALI system may serve as a physiological model for study interactions of HBoV1 and host cells, and a system for antiviral discovery as well. Imai-Matsushima et al 109 Primary liver cancer is the 6th most frequent cancer type globally with high mortality, partially due to the lack of effective therapeutic options. The leading cause of liver cancer is cirrhosis due to viral hepatitis (HBV and HCV), aflatoxin, nonalcoholic fatty liver disease, or alcohol. The most common type is hepatocellular carcinoma These suggest that CR technology can be used for expansion of normal and tumor cells in GU system. These cells may serve an ex vivo models for studies of viral infections in genital-urology, for example, SASR-CoV-2 induced injury of the kidney. World Health Organization (WHO) 116 declared the coronavirus disease-2019 (COVID-19) or SARS-CoV-2 infection outbreak as a "public health emergency of international concern," and characterized COVID-19 as a "pandemic" on 30 January and 11 March 2020, respectively. 117 Patients with COVID-19 have ranged from asymptomatic (or very mild), mild, moderate, severe, to critical severe illness resulting in death. [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] While around 80% of COVID-19 patients have mild symptoms, some patients may progress to pneumonia even to multiorgan failure involving the lung, heart, and kidney. [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] The rate of death among confirmed patients is estimated to be 5% but varies by age and other health conditions. [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] The mechanisms of how SARS-CoV-2 infects human airway epithelial cells and also causes severe multiorgan failure are largely unknown. COVID-19 patients at the early stage of or asymptomatic or mild symptomatic patients usually have rapid replication of viruses at upper airway. Whether or not SARS-CoV-2 spreads to lower airway track is due to virus-host interaction, innate response, and local immune response. Severe COVID-19 patients with multiorgan injury are usually due less to virus replication-based direct injury and more to immunopathogenic injuries ( Figure 3 ). SARS-CoV-2 and SARS-CoV share the same functional host-cell receptor ACE2, [130] [131] [132] [133] [134] and that SARS-CoV-2 possesses crucial amino acid residues for ACE2 binding. 133 ACE2 predominantly expresses in vascular endothelial cells, kidney and heart tissues, small intestine, and testes. 135 Recently, two reports demonstrated large amounts of SARS-CoV-2 in the upper airway and saliva. 116, 123 Human-related physiological models are urgently needed for these studies of body site-specific or tissue-specific viral replication, innate immune response, and infectivity. As a functional and biological system, CR coupled with ALI/LLI culture will facilitate these studies and development of novel therapeutics ( Figure 1 ). Indeed, early study on SARS-CoV indicates that host cell differentiation or polarized epithelium and expression of ACE2 are both important for the susceptibility of human airway epithelia to SARS-CoV viral infection. 136 Indeed, Baric lab at UNC has used for ALI cultures of human airway epithelial cells (HAEs) for functional drug screening of SARS-CoV and SARS-CoV-2. 137, 138 To overcome the difficulties with stable source and expense of primary human normal cells and variability of donors, CRCs from airway, GI, F I G U R E 3 Proposed diagram of SARS-CoV-2 replication and immunopathogenic injuries for COVID-19 patients. COVID-19, coronavirus disease-2019; SARS-CoV-2, severe acute respiratory syndrome coronavirus-2 GU tracts in combination with ALI or LLI will be a better choice for physiological systems for SARS-CoV-2 studies (Figure 1 ). Owing to the limitations of current cell line and animal models, there is an urgent need for human physiological cell models for the study of viral infections and discovery of antiviral drugs. Here, we summarized the long-term cultures for human normal epithelial cells from respiratory tract, GI, and GU tracts using CR technology. Their cultures provide a stable source for normal cells from individuals and populations (race, age, gender, geography, etc.); CRC-coupled ALI/LLI/Organoids technologies (Figure 1 ) may serve as ex vivo physiological models for host-virus interactions and human viral disease, especially emerging and re-emerging virus infections. These will facilitate studies of virus entry, innate immune responses, viral replications, and drug discovery. Conditional reprogramming for patient-derived cancer models and next-generation living biobanks Conditional reprogramming inducing clinical cells proliferation: new research tools in tumor and inflammatory-related diseases ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells Radiation induces diffusible feeder cell factor(s) that cooperate with ROCK inhibitor to conditionally reprogram and immortalize epithelial cells Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens Tumor organoids as a pre-clinical cancer model for drug discovery Patient derived organoids to model rare prostate cancer phenotypes A living biobank of breast cancer organoids captures disease heterogeneity Mouse and human urothelial cancer organoids: a tool for bladder cancer research Organoids for replacement therapy: expectations, limitations and reality Precision medicine for cancer with next-generation functional diagnostics Precision oncology: the road ahead Generation of human nasal epithelial cell spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer Continuous culture of urine-derived bladder cancer cells for precision medicine Establishment of 15 cancer cell lines from patients with lung cancer and the potential tools for immunotherapy Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer Abstract 1569: next generation cell line models: conditionally reprogrammed cells Facilitated primary culture and amplification of breast cancer cells and their biological properties Genomic comparison of early-passage conditionally reprogrammed breast cancer cells to their corresponding primary tumors Abstract 816: Molecular and genomic characterization of a newly established male breast cancer cell line Patient-derived models of acquired resistance can identify effective drug combinations for cancer Primary patient-derived cancer cells and their potential for personalized cancer patient care CRIPTO1 expression in EGFRmutant NSCLC elicits intrinsic EGFR-inhibitor resistance Heterogeneity underlies the emergence of egfrt790 wild-type clones following treatment of t790m-positive cancers with a third-generation EGFR inhibitor MYB fusions and CD markers as tools for authentication and purification of cancer stem cells from salivary adenoid cystic carcinoma Pharmacological rescue of conditionally reprogrammed cystic fibrosis bronchial epithelial cells Long-term culture and cloning of primary human bronchial basal cells that maintain multipotent differentiation capacity and CFTR channel function Conditionally reprogrammed primary airway epithelial cells maintain morphology, lineage and disease specific functional characteristics Characterization of primary human mammary epithelial cells isolated and propagated by conditional reprogrammed cell culture Airway progenitor clone formation is enhanced by Y-27632-dependent changes in the transcriptome Non-malignant epithelial cells preferentially proliferate from nasopharyngeal carcinoma biopsy cultured under conditionally reprogrammed conditions Human lung epithelial cells divide >200 population doublings without engaging a telomere maintenance mechanism. bioRxiv The expansion of the oral mucosa epithelial cells in vitro in conditioned culture media supplemented with Y27632 Abstract 3918: characterizing growth features, allograft generation and transcriptomes of cultured conditionally reprogrammed cells (CRC) prepared from primary triple negative cancer from Brca1-mutant mice Fidelity of a PDX-CR model for bladder cancer Continuous culture of urine-derived bladder cancer cells for precision medicine Expanding primary cells from mucoepidermoid and other salivary gland neoplasms for genetic and chemosensitivity testing HPV positive neuroendocrine cervical cancer cells are dependent on Myc but not E6/E7 viral oncogenes Murine neuroblastoma cell lines developed by conditional reprogramming preserve heterogeneous phenotypes observed in vivo Conditional cell reprogramming involves non-canonical beta-catenin activation and mTOR-mediated inactivation of Akt Multifactorial analysis of conditional reprogramming of human keratinocytes Proliferation of human hepatocellular carcinoma cells from surgically resected specimens under conditionally reprogrammed culture Establishment of ornithine transcarbamylase deficiency-derived primary human hepatocyte with hepatic functions Primary cancer cell culture: mammary-optimized vs conditional reprogramming Derivation and osmotolerance characterization of three immortalized tilapia (Oreochromis mossambicus) cell lines Conditional reprogrammed human limbal epithelial cells represent a novel in vitro cell model for drug responses Long-term expansion of primary equine keratinocytes that maintain the ability to differentiate into stratified epidermis Development of a polarized pancreatic ductular cell epithelium for physiological studies Most canine ameloblastomas harbor HRAS mutations, providing a novel large-animal model of RAS-driven cancer Ability to generate patient-derived breast cancer xenografts is enhanced in chemoresistant disease and predicts poor patient outcomes Generation of stable PDX derived cell lines using conditional reprogramming Human ex vivo 3D bone model recapitulates osteocyte response to metastatic prostate cancer Optimized isolation and expansion of human airway epithelial basal cells from endobronchial biopsy samples CRISPR-Cas9-mediated gene knockout in primary human airway epithelial cells reveals a proinflammatory role for MUC18 Genome editing of human primary keratinocytes by CRISPR/Cas9 reveals an essential role of the NLRP1 inflammasome in UVB sensing Establishment of primary transgenic human airway epithelial cell cultures to study respiratory virus-host interactions Long-term culture and cloning of primary human bronchial basal cells that maintain multipotent differentiation capacity and CFTR channel function Dual SMAD signaling inhibition enables long-term expansion of diverse epithelial basal cells Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-myosin II and TGF-beta signaling Rho/SMAD/mTOR triple inhibition enables long-term expansion of human neonatal tracheal aspirate-derived airway basal cell-like cells Conditional reprogramming of pediatric human esophageal epithelial cells for use in tissue engineering and disease investigation Conditional reprogramming of pediatric airway epithelial cells: a new human model to investigate early-life respiratory disorders Conditional reprogramming cells are novel tools for drug response assay and the development of personalized medicine in luminal-B breast cancer Highlight article: Long-term culture and characterization of patient-derived primary hepatocytes using conditional reprogramming Cystic fibrosis transmembrane conductance regulator potentiation as a therapeutic strategy for pulmonary edema: a proof-of-concept study in pigs Use of reprogrammed cells to identify therapy for respiratory papillomatosis Conditionally reprogrammed normal and transformed mouse mammary epithelial cells display a progenitor-cell-like phenotype CRISPR-Cas9-mediated gene knockout in primary human airway epithelial cells reveals a proinflammatory role for MUC18 Human normal bronchial epithelial cells: a novel in vitro cell model for toxicity evaluation Adenovirus entry from the apical surface of polarized epithelia is facilitated by the host innate immune response Pseudoimmortalization of postnatal cochlear progenitor cells yields a scalable cell line capable of transcriptionally regulating mature hair cell genes Screening of conditionally reprogrammed patient-derived carcinoma cells identifies ERCC3-MYC interactions as a target in pancreatic cancer Co-culture-expanded human basal epithelial stem cells for application in tracheal tissue engineering Generation of a C57BL/6 MYC-driven mouse model and cell line of prostate cancer Patient-derived induced pluripotent stem cells in cancer research and precision oncology 462-High-throughput drug screening using conditionally reprogrammed patientderived cell lines in bladder cancer Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity Reconstituting mouse lungs with conditionally reprogrammed human bronchial epithelial cells Generation of renewable mouse intestinal epithelial cell monolayers and organoids for functional analyses Conditional reprogrammed human limbal epithelial cells represent a novel in vitro cell model for drug responses Conditionally reprogrammed human normal bronchial epithelial cells express comparable levels of cytochromes p450 and are sensitive to BaP induction High-throughput screening identifies candidate drugs for the treatment of recurrent respiratory papillomatosis Personalized drug sensitivity screening for bladder cancer using conditionally reprogrammed patient-derived cells Conditionally reprogrammed patient-derived cells: a step forward towards personalized medicine? African-American prostate normal and cancer cells for health disparities research Breaking the in vitro alveolar type II cell proliferation barrier while retaining ion transport properties Focus on nasopharyngeal carcinoma Comprehensive high-throughput RNA sequencing analysis reveals contamination of multiple nasopharyngeal carcinoma cell lines with HeLa cell genomes Authentication of nasopharyngeal carcinoma tumor lines Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus Establishment of a nasopharyngeal carcinoma cell line capable of undergoing lytic Epstein-Barr virus reactivation Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma Efficient replication of Epstein-Barr virus in stratified epithelium in vitro Use of reprogrammed cells to identify therapy for respiratory papillomatosis Sp100 provides intrinsic immunity against human papillomavirus infection Persistence of an oncogenic papillomavirus genome requires cis elements from the viral transcriptional enhancer Comparison of paired human nasal and bronchial airway epithelial cell responses to rhinovirus infection and IL-13 treatment Dual RNAseq reveals viral infections in asthmatic children without respiratory illness which are associated with changes in the airway transcriptome Human bocavirus as the cause of a life-threatening infection Human bocavirus can be cultured in differentiated human airway epithelial cells Replication of an autonomous human parvovirus in non-dividing human airway epithelium is facilitated through the DNA damage and repair pathways Human parvovirus infection of human airway epithelia induces pyroptotic cell death by inhibiting apoptosis Ex vivo 2D and 3D HSV-2 infection model using human normal vaginal epithelial cells Effects of female sex hormones on susceptibility to HSV-2 in vaginal cells grown in air-liquid interface The antiviral drug arbidol inhibits Zika virus Long-term culture of distal airway epithelial cells allows differentiation towards alveolar epithelial cells suited for influenza virus studies Expanding and characterizing esophageal epithelial cells obtained from children with eosinophilic esophagitis Monoclonal antibody 3H11 chimeric antigen receptors enhance T cell effector function and exhibit efficacy against gastric cancer Conditionally reprogrammed colorectal cancer cells combined with mouse avatars identify synergy between EGFR and MEK or CDK4/6 inhibitors Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cells Personalized drug sensitivity screening for bladder cancer using conditionally reprogrammed patient-derived cells Characterization of the effects of defined, multidimensional culture conditions on conditionally reprogrammed primary human prostate cells Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study Coronavirus disease 2019 (COVID-19). Situation Report-58 Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis A review of coronavirus disease-2019 (COVID-19) SARS-CoV-2 viral load in upper respiratory specimens of infected patients COVID-19 with spontaneous pneumomediastinum Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19 Liver injury in COVID-19: management and challenges Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a singlecentered, retrospective, observational study Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention Comorbidities and multi-organ injuries in the treatment of COVID-19 Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation Receptor recognition by the novel coronavirus from Wuhan: an analysis based on Decade-Long Structural Studies of SARS coronavirus Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor A pneumonia outbreak associated with a new coronavirus of probable bat origin Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia An orally bioavailable broadspectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice How to cite this article: Liu X, Mondal AM. Conditional cell reprogramming for modeling host-virus interactions and human viral diseases